Cargando…

Rosiglitazone and Fenofibrate Additive Effects on Lipids

Background. To evaluate the effect of rosiglitazone, fenofibrate, or their combined use on plasma lipids in normoglycemic healthy adults. Methods and Results. Subjects were randomized in a double-blind fashion to rosiglitazone + placebo, fenofibrate + placebo, rosiglitazone + fenofibrate, or matchin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Slim, Ahmad, Castillo-Rojas, Laudino, Hulten, Eddie, Slim, Jennifer N., Pearce Moore, Dorette, Villines, Todd C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227227/ https://www.ncbi.nlm.nih.gov/pubmed/22162805 http://dx.doi.org/10.1155/2011/286875

Ejemplares similares

The Effects of Extended Release Niacin in Combination with Omega 3 Fatty Acid Supplements in the Treatment of Elevated Lipoprotein (a)
por: Helmbold, Alan F., et al.
Publicado: (2010)

Chamber dimensions and functional assessment with coronary computed tomographic angiography as compared to echocardiography using American Society of Echocardiography guidelines
por: Rose, Michael, et al.
Publicado: (2014)

The Effect of Airway Pressure Release Ventilation on Pulmonary Catheter Readings: Specifically Pulmonary Capillary Wedge Pressure in a Swine Model
por: Slim, Ahmad M., et al.
Publicado: (2011)

Treatment in a preventive cardiology clinic utilizing advanced practice providers effectively closes atherosclerotic cardiovascular disease risk‐management gaps among a primary‐prevention population compared with a propensity‐matched primary‐care cohort: A team‐based care model and its impact on lipid and blood pressure management
por: Fentanes, Emilio, et al.
Publicado: (2018)

Long-Term Consequences of Hepatitis C Viral Clearance on the CD4 (+) T Cell Lymphocyte Course in HIV/HCV Coinfected Patients
por: Dazley, J., et al.
Publicado: (2015)

Effect of Rosiglitazone and Insulin Combination Therapy on Inflammation Parameters and Adipocytokine Levels in Patients with Type 1 DM
por: Guclu, Metin, et al.
Publicado: (2015)

Open versus Endovascular Repair of Abdominal Aortic Aneurysm in the Elective and Emergent Setting in a Pooled Population of 37,781 Patients: A Systematic Review and Meta-Analysis
por: Thomas, Dustin M., et al.
Publicado: (2014)

PPARα Agonist Fenofibrate Reduced the Secreting Load of β-Cells in Hypertriglyceridemia Patients with Normal Glucose Tolerance
por: Liu, Jia, et al.
Publicado: (2016)

Antidiabetic Rosiglitazone Reduces Soluble Intercellular Adhesion Molecule-1 Level in Type 2 Diabetic Patients with Coronary Artery Disease
por: Wang, Guang, et al.
Publicado: (2008)

A phase II trial with rosiglitazone in liposarcoma patients
por: Debrock, G, et al.
Publicado: (2003)

Comparison of Predicted Exercise Capacity Equations and the Effect of Actual versus Ideal Body Weight among Subjects Undergoing Cardiopulmonary Exercise Testing
por: Ahmadian, H. Reza, et al.
Publicado: (2013)

Coronary Artery Calcium Testing in Symptomatic Patients: An Issue of Diagnostic Efficiency
por: McBride, Chad B., et al.
Publicado: (2013)

Rosiglitazone attenuates hypoxia-induced renal cell apoptosis by inhibiting NF-κB signaling pathway in a PPARγ-dependent manner
por: Wei, Jun-Yu, et al.
Publicado: (2022)

Assessment of major adverse cardiovascular events and ischemic stroke with coronary computed tomography angiography based upon angiographic diagnosis in a high-volume single center
por: Lin, Charles K, et al.
Publicado: (2014)

Rate of Corneal Collagen Crosslinking Redo in Private Practice: Risk Factors and Safety
por: Antoun, Joelle, et al.
Publicado: (2015)

Correlation of Circulating Acid-Labile Subunit Levels with Insulin Sensitivity and Serum LDL Cholesterol in Patients with Type 2 Diabetes: Findings from a Prospective Study with Rosiglitazone
por: Lai, Ying-Chuen, et al.
Publicado: (2014)

Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis
por: Bennett, Robert G, et al.
Publicado: (2017)

Associations of Fenofibrate Therapy With Incidence and Progression of CKD in Patients With Type 2 Diabetes
por: Frazier, Rebecca, et al.
Publicado: (2018)

The Efficacy of Fenofibrate in Addition to Atorvastatin in Patients of Type II Diabetes Mellitus
por: Qasim, Muhammad, et al.
Publicado: (2022)

Incorporation of Organic Growth Additives to Enhance In Vitro Tissue Culture for Producing Genetically Stable Plants
por: Hamdeni, Imtinene, et al.
Publicado: (2022)

Effects of fenofibrate therapy on renal function in primary gout patients
por: Li, Xinde, et al.
Publicado: (2021)

Preparation and Evaluation of Lipid-Based Liquid Crystalline Formulation of Fenofibrate
por: Kazemi, Moloud, et al.
Publicado: (2018)

Paradoxical Reduction in HDL-C With Fenofibrate and Thiazolidinedione Therapy in Type 2 Diabetes: The ACCORD Lipid Trial
por: Linz, Peter E., et al.
Publicado: (2014)

Leukemia and rosiglitazone
por: Yavasoglu, Irfan, et al.
Publicado: (2016)

A Review of Currently Available Fenofibrate and Fenofibric Acid Formulations
por: Ling, Hua, et al.
Publicado: (2013)

Management of Coronary Artery Calcium and Coronary CTA Findings
por: Thomas, Dustin M., et al.
Publicado: (2015)

Ingestion of Leucine + Phenylalanine with Glucose Produces an Additive Effect on Serum Insulin but Less than Additive Effect on Plasma Glucose
por: Iverson, Jennifer F., et al.
Publicado: (2013)

Variants Identified in a GWAS Meta-Analysis for Blood Lipids Are Associated with the Lipid Response to Fenofibrate
por: Aslibekyan, Stella, et al.
Publicado: (2012)

Effect of Combination Therapy With Fenofibrate and Simvastatin on Postprandial Lipemia in the ACCORD Lipid Trial
por: Reyes-Soffer, Gissette, et al.
Publicado: (2013)

Effects of rosiglitazone on serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes mellitus
por: Atamer, Y., et al.
Publicado: (2013)

Fatal Aortic Dissection in a Patient with Giant Cell Arteritis: A Case Report and Review of the Literature
por: Nayar, Anjeli K., et al.
Publicado: (2013)

The Janus face of rosiglitazone
por: Pich, Christine, et al.
Publicado: (2018)

A Case of Congenitally Corrected Transposition of the Great Arteries Discovered on Coronary Computed Tomography
por: Marler, Adam T., et al.
Publicado: (2013)

A Rare Case of Effusive Constrictive Cholesterol Pericarditis: A Case Report and Review
por: Adamson, Van W., et al.
Publicado: (2013)

Fenofibrate: a novel formulation (Triglide™) in the treatment of lipid disorders: a review
por: Tziomalos, Konstantinos, et al.
Publicado: (2006)

A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapy
por: Strain, Joe D, et al.
Publicado: (2010)

Phase I study investigating the safety and feasibility of combining imatinib mesylate (Gleevec) with sorafenib in patients with refractory castration-resistant prostate cancer
por: Nabhan, C, et al.
Publicado: (2012)

Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial
por: Komajda, Michel, et al.
Publicado: (2010)

Platypnea-Orthodeoxia: An Unusual Case of Hypoxemia
por: Slim, Jennifer, et al.
Publicado: (2011)

PPAR-α Agonist Fenofibrate Decreased RANTES Levels in Type 2 Diabetes Patients with Hypertriglyceridemia
por: Feng, Xiaomeng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_l2t3i6r8bu8og3lkptd1dm1qqi